Phenol in Dermatology: Updated Evidence on Efficacy and Safety

August 2025 in “ Anais Brasileiros de Dermatologia ”

Carolina Reato Marçon

phenol alopecia areata vitiligo acne scars deep peels neocollagenesis cardiac arrhythmias organ failure

Studysummary This review details phenol's dermatological uses and underscores its potent skin rejuvenation effects but emphasizes the need for caution due to risks of serious complications, including cardiac arrhythmias and organ failure, particularly with improper use or large-area applications.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

Phenol is a versatile agent in dermatology, effective for conditions like alopecia areata, acne scars, and pilonidal cysts, with studies showing a 78% positive response in 50 alopecia areata patients and a 95% success rate in pilonidal cyst treatment. It promotes collagen production and skin renewal but poses significant risks of systemic toxicity, including cardiac arrhythmias and organ failure, necessitating rigorous safety protocols and specialist supervision. The document emphasizes the importance of controlled medical use, careful patient selection, and the need for additional studies to determine safe doses and explore long-term effects.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Evaluation of Utility of Phenol in Alopecia Areata

9 citations , January 2013 in “International journal of trichology”

This study found that 88% phenol treatment significantly improved texture, pigmentation, and density of hair regrowth in alopecia areata patients over nine weeks, with 78% showing a good to excellent response.

research Alopecia Areata Treated with Phenolization and Intravenous Dexamethasone Pulses

1 citations , January 2013 in “International journal of trichology”

The researchers reported a case of a young girl with alopecia areata who responded well to a combination therapy of 88% phenol and dexamethasone, with no recurrence observed during six months of follow-up.